Literature DB >> 17910739

Changes in leptin, ghrelin, growth hormone and neuropeptide-Y after an acute model of MDMA and methamphetamine exposure in rats.

Firas H Kobeissy1, Jennifer A Jeung, Matthew W Warren, Jacqueline E Geier, Mark S Gold.   

Abstract

Club drug abuse is a growing problem in the United States. Beyond addiction and toxicity are endocrine effects which are not well characterized. Specifically, the changes in appetite following exposure to drugs of abuse are an interesting but poorly understood phenomenon. Serum hormones such as leptin, ghrelin, growth hormone (GH), and neuropeptide-Y (NP-Y) are known to affect appetite, but have not been studied extensively with drugs of abuse. In this work, we examine the effects of club drugs 3,4-methylenedioxymethamphetamine (MDMA) (ecstasy) and methamphetamine (METH) (doses of 5, 20 and 40 mg/kg) on serum concentrations of these hormones in adult male Sprague-Dawley rats 6, 12, 24 and 48 hours after drug administration. In a dose-dependent manner, MDMA was shown to cause transient significant decreases in serum leptin and GH followed by a base line recovery after 24 hours. Conversely, serum ghrelin increased and normalized after 24 hours. Interestingly, serum NP-Y showed a steady decrease in both treatment of MDMA and METH at different time points and dosages. In humans, abuse of these drugs reduces eating. As evident from these data, acute administration of METH and MDMA had significant effects on different serum hormone levels involved in appetite regulation. Future studies should be performed to see how chronic, low dose drug administration would affect hormone levels and try to answer questions about the physiological mechanisms involved in the anorexic paradigm observed in drug use.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17910739     DOI: 10.1111/j.1369-1600.2007.00083.x

Source DB:  PubMed          Journal:  Addict Biol        ISSN: 1355-6215            Impact factor:   4.280


  16 in total

Review 1.  Hormonal and neural mechanisms of food reward, eating behaviour and obesity.

Authors:  Susan Murray; Alastair Tulloch; Mark S Gold; Nicole M Avena
Journal:  Nat Rev Endocrinol       Date:  2014-06-24       Impact factor: 43.330

Review 2.  Effects of nicotine on homeostatic and hedonic components of food intake.

Authors:  Andrea Stojakovic; Enma P Espinosa; Osman T Farhad; Kabirullah Lutfy
Journal:  J Endocrinol       Date:  2017-10       Impact factor: 4.286

3.  Sensitivity to Chronic Methamphetamine Administration and Withdrawal in Mice with Relaxin-3/RXFP3 Deficiency.

Authors:  Mouna Haidar; Monica Lam; Berenice E Chua; Craig M Smith; Andrew L Gundlach
Journal:  Neurochem Res       Date:  2015-05-29       Impact factor: 3.996

4.  Relationship between gut and sepsis: Role of ghrelin.

Authors:  Undurti N Das
Journal:  World J Diabetes       Date:  2011-01-15

5.  The effects of dose and repeated administration on the longer-term hypophagia produced by amphetamine in rats.

Authors:  Wesley White; Marcus B Hundley; Ilsun M White
Journal:  Pharmacol Biochem Behav       Date:  2010-09-17       Impact factor: 3.533

6.  Ghrelin receptor antagonism attenuates cocaine- and amphetamine-induced locomotor stimulation, accumbal dopamine release, and conditioned place preference.

Authors:  Elisabet Jerlhag; Emil Egecioglu; Suzanne L Dickson; Jörgen A Engel
Journal:  Psychopharmacology (Berl)       Date:  2010-06-19       Impact factor: 4.530

Review 7.  The role of ghrelin in addiction: a review.

Authors:  Vassilis N Panagopoulos; Elizabeth Ralevski
Journal:  Psychopharmacology (Berl)       Date:  2014-06-20       Impact factor: 4.530

Review 8.  Stress, Motivation, and the Gut-Brain Axis: A Focus on the Ghrelin System and Alcohol Use Disorder.

Authors:  Laurel S Morris; Valerie Voon; Lorenzo Leggio
Journal:  Alcohol Clin Exp Res       Date:  2018-05-24       Impact factor: 3.455

9.  Methamphetamine-associated cleavage of the synaptic adhesion molecule intercellular adhesion molecule-5.

Authors:  Katherine Conant; Irina Lonskaya; Arek Szklarczyk; Caroline Krall; Joseph Steiner; Kathleen Maguire-Zeiss; Seung T Lim
Journal:  J Neurochem       Date:  2011-01-19       Impact factor: 5.546

10.  The Chronic Oral Administration of Clobenzorex or Amphetamine Decreases Motor Behavior and Induces Glial Activation in the Striatum Without Dopaminergic Degeneration.

Authors:  Grego David Apóstol Del Rosal; Ilhuicamina Daniel Limón; Isabel Martínez; Aleidy Patricio-Martínez
Journal:  Neurotox Res       Date:  2021-07-19       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.